Navigation Links
Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
Date:9/25/2007

National Speakers and Panelists to Discuss Trends, Trials, and Innovation

in Cardiovascular Medicine at Upcoming Conferences

CLEVELAND, Sept. 25 /PRNewswire/ -- Cleveland Clinic is hosting two upcoming Summits that will focus on medical innovation and emerging trends in cardiovascular medicine.

-- Oct. 1-3: Innovation is driving the development of new therapies,

treatments and devices to treat cardiovascular disease. The 5th annual

Cleveland Clinic Medical Innovation Summit will examine trends in

medical innovation and cardiovascular technologies. The Innovation

Summit is an international gathering of health care, business and media

leaders and other decision-makers to dissect advances revolutionizing

health care and how to accelerate the application of life-saving

medical technologies. Also featured will be the Cleveland Clinic's

annual selection of the "Top 10" health care innovations, live,

interactive surgeries and in-depth debates on industry challenges. For

more information on the Medical Innovation Summit, including the

agenda, please visit

http://www.clevelandclinic.org/innovations/summit/.

-- Oct. 18-20: Cleveland Clinic Kaufman Center for Heart Failure, in

cooperation with the American Association for Thoracic Surgery (AATS)

and the American College of Cardiology Foundation (ACCF), will present

an advanced review of emerging medical and surgical treatments of heart

failure. The Summit, called the 21st Century Treatment of Heart

Failure, will feature presentations by leading names in cardiovascular

medicine and cardiac surgery. Topics will include: new therapies to

reverse remodeling; drugs, genes, and cellular targets; the newest

assist devices, with an update on the total artificial heart and rotary

pumps; the latest treatment guidelines; and breakthrough findings on

the epidemiology of systolic and diastolic heart failure.

The Summits will feature internationally recognized speakers and offer unparalleled insight into the driving forces in the world of medical innovation. Each will explore in detail, the blurring of traditional boundaries between medical industry segments and clinical specialties that is driving increased market consolidation, the emergence of new business models and the evolution of imaginative forms of collaboration.

CCF Innovations, the technology commercialization arm of Cleveland Clinic, organizes the Medical Innovation Summit and stewards the Clinic's technology innovation strategy. It enhances product-oriented innovation throughout Cleveland Clinic and transforms promising therapies, devices and diagnostics into beneficial medical products, via spin-off companies, licensees and equity partnerships.

The Kaufman Center for Heart Failure facilitates Cleveland Clinic's participation in national and international clinical trials of investigational treatments and more aggressive or innovative uses of standard heart failure therapies. Cardiologists, cardiac surgeons and researchers collaborate on early diagnosis of congestive heart failure and more aggressive use of therapies to prevent myocardial damage.

Cleveland Clinic Heart & Vascular Institute is the recognized world leader in diagnosis and treatment of cardiovascular disease. Cleveland Clinic has been ranked No. 1 in the nation for cardiac care by U.S. News & World Report every year since 1995.

Cleveland Clinic, located in Cleveland, Ohio, is a not-for-profit multispecialty academic medical center that integrates clinical and hospital care with research and education. Cleveland Clinic was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. U.S. News & World Report consistently names Cleveland Clinic as one of the nation's best hospitals in its annual "America's Best Hospitals" survey. Approximately 1,500 full-time salaried physicians at Cleveland Clinic and Cleveland Clinic Florida represent more than 100 medical specialties and subspecialties. In 2005, there were 2.9 million outpatient visits to Cleveland Clinic. Patients came for treatment from every state and from more than 80 countries. There were nearly 54,000 hospital admissions to Cleveland Clinic in 2005. Cleveland Clinic's Web site address is http://www.clevelandclinic.org.


'/>"/>
SOURCE Cleveland Clinic
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Cleveland BioLabs Protectan CBLB502 Demonstrates Strong Survival Benefits as Mitigator Against Radiation-Induced Damage in Study
2. Cholesterol Drug Fails to Slow Progression of Coronary Disease, Cleveland Clinic Study Reports
3. Genetic Analysis Systems Enter the Clinical Mainstream
4. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
5. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
6. Sygnis Pharma AG announces date for presentation of clinical results
7. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
9. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
10. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
11. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Denmark , March 23, 2017 Ascendis ... its innovative TransCon technology to address significant unmet medical ... will host a conference call and webcast on Monday, ... the Endocrine Society in Orlando, Florida ... disease pipeline candidates (TransCon Growth Hormone, TransCon PTH and ...
(Date:3/23/2017)... INVICTUS MD STRATEGIES CORP. ("Invictus MD" or the "Company") (CSE: ... AB Laboratories Inc. ("AB Labs") has successfully completed several ... Access to Cannabis for Medical Purposes Regulations ("ACMPR") located ... The facility, which was licensed for Cultivation under ... half capacity, with full production capacity scheduled by the ...
(Date:3/23/2017)... , March 23, 2017 ... vendor landscape with the top five players accounting ... 2015. These companies are Stryker Sustainability Solutions, Ethicon ... Services, Inc., and VANGUARD AG. Despite the high ... market is witnessing the prevalence of fierce competition ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... ... Inflow IQ & Inflownomics of Raleigh, NC introduce a powerful information access ... As experts in dangerous situations the Inflow IQ team can help people. Get ... clean & refreshing knowledge systems that enhance life. , Authentically enjoy ...
(Date:3/23/2017)... ... March 23, 2017 , ... The Leaders ... life-altering and fatal diseases in opposition to the President’s Fiscal Year 2018 ... care, services, and hope for the most vulnerable among us. , The proposed ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... with European Guidelines and the New MEDDEV 2.7/1 Rev. 4 Guidance, **An ... http://www.fdanews.com/mdclineval                  , How will the new EU MDR language change ...
(Date:3/23/2017)... DC (PRWEB) , ... March 23, 2017 , ... News ... Dental Choice has helped score a major victory in Europe for public health and ... , Based on rigorous scientific research and the overwhelming support of European ...
(Date:3/23/2017)... ... March 23, 2017 , ... “My Journey Through Heaven”: the ... an infinitely more profound faith of God’s promise of Heaven for His people. “My ... spends each day with his wife, three children and six grandchildren living and doing ...
Breaking Medicine News(10 mins):